PeopleBio, Inc. (KOSDAQ:304840)

South Korea · Delayed Price · Currency is KRW

561.00

-9.00 (-1.58%)

At close: Jul 31, 2026

Market Cap	13.61B -73.4%
Revenue (ttm)	3.84B +119.8%
Net Income	-15.72B
EPS	-696.76
Shares Out	24.26M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	458,520
Open	578.00
Previous Close	570.00
Day's Range	561.00 - 646.00
52-Week Range	561.00 - 2,870.00
Beta	0.63
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2002

Employees 26

Stock Exchange KOSDAQ

Ticker Symbol 304840

Full Company Profile

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.

Financial Statements